Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

N024: Changing face of care for patients with moderate-to-severe inflammatory bowel disease: The role of specialist nurses in the governance of anti-TNFα prescribing in RomaniaECCO '18 Vienna
Year: 2018
Authors:

A.S. Leca1*, O. Timofte2, D. Mihnea3, N. Melinte3, G.G. Balan2,3, C. Stanciu3

1Emergency County Hospital Saint Spiridon, Institute of Gastroenterology and Hepatology, Iasi, Romania, 2"Gr.T.Popa" University of Medicine and Pharmacy, Gastroenterology, Iasi, Romania, 3Institute of Gastroenterology and Hepatology, Gastroenterology, Iasi, Romania

N025: Diversity at the workplace and responsibility at work positively impact the tendency towards own professional marketing among nurses in gastroenterologyECCO '18 Vienna
Year: 2018
Authors:

R. Barkan1*, I. Goren1,2, H. Iting3, I. Kagan4, R. Kigli4, K. Rabinowitz2,5, I. Dotan1,2, H. Yanai1,2

1Rabin medical center, Division of Gastroenterology, Petah Tikva, Israel, 2The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 3Tel Aviv Sourasky Medical Center, Department of Orthopedics, Tel Aviv, Israel, 4Department of Nursing, Tel Aviv University, Tel Aviv, Israel, 5Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva, Israel

N026: IBDoc® self-care/point-of-care calportectin test: Early value in a district general hospital inflammatory bowel disease serviceECCO '18 Vienna
Year: 2018
Authors:

P. Avery1*, R. Wilson1,2

1Dorset County Hospital Foundation Trust, Gastroenterology, Dorchester, UK, 2Dorset County Hospital Foundation Trust, Gastroenterology, Dorchester, UK

N027: Telephone/email service provided to IBD patients by Canadian IBD nursesECCO '18 Vienna
Year: 2018
Authors:

U. Chauhan1*, O.–I. Nistor2, B. Currie3, J. Nicholl4, W. McCaw5, M. Watson6, L. Westin7, A. Fernandes8, C. Norton9

1Hamilton Health Sciences, Digestive Disease, Hamilton, Canada, 2Halton Healthcare, Oakville, Canada, 3QEII Health Sciences Centre, Halifax, Canada, 4Inomar Strategies, Oakville, Canada, 5Robarts Clinical Trials, London, Canada, 6London Health Sciences Centre, London, Canada, 7Red Deer Regional Hospital, Red Deer, Canada, 8McMaster University, Hamilton, Canada, 9King's College London, Waterloo, UK

N029: Patients experience of advice received on the use of topical therapies in inflammatory bowel disease (IBD)ECCO '18 Vienna
Year: 2018
Authors:

T. Tyrrell1*, L. Whitley2, J. Adio3, K. Greveson4, A. Hall5, H. Yarrow6, L. Medcalf7, H. Parker2

1St. Mark's Hospital, IBD Unit, Harrow, UK, 2University College London Hospital, IBD Unit, London, UK, 3St. Mark's Hospital, IBD Unit, London, UK, 4Royal Free Hospital, IBD Unit, London, UK, 5Homerton University Hospital, Department of Gastroenterology, London, UK, 6Guy's and St. Thomas Hospital, IBD Unit, London, UK, 7King's College Hospital, IBD Unit, London, UK

N030: Real benefits of IBD nurse-led clinics: Improving awareness and uptake of the HPV vaccine in IBD patientsECCO '18 Vienna
Year: 2018
Authors:

A. Keogh*, M. Burke

University Hospital Galway, Gastroenterology, Galway, Ireland

N031: The effect of web-based education on disease activity, symptom management, and quality of life on patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

B.N. Ozgursoy Uran1,2*, Y. Yildirim3, F. Senuzun Aykar3, B. Unsal1

1Izmir Katip Celebi University, Faculty of Medicine, Internal Medicine Department, Izmir, Turkey, 2Izmir Katip Celebi University, Health Science Faculty, Nursing Department, Izmir, Turkey, 3Ege University, Faculty of Nursing, Department of Internal Medicine Nursing, Izmir, Turkey

N032: Impact of pain due to subcutaneous administration of a biological drugECCO '18 Vienna
Year: 2018
Authors:

C. Gely1, L. Marin2, J. Gordillo1*, M. Mañosa2,3, F. Bertoletti1, F. Cañete2, C. Gonzalez-Muñosa1, E. Cabré2,3, E. Domènech2,3, E. Garcia-Planella1

1Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 2Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 3Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas (CIBEREHD), Barcelona, Spain

N033: Young adults living with inflammatory bowel disease. A thematic synthesis of patient experienceECCO '18 Vienna
Year: 2018
Authors:

S. Fourie1,2*, D. Jackson1, H. Aveyard1, A. Simmons2

1Oxford Brookes University, Oxford Institute of Nursing, Midwifery and Allied Health Research, Oxford, UK, 2University of Oxford, Nuffield Department of Medicine, Oxford, UK

N034: Patient satisfaction with brand changes of Mesalazine medications in four hospitals in the North West of EnglandECCO '18 Vienna
Year: 2018
Authors:

R. Campbell1*, E. Nelson2, J. Hocking3, J. Hodgins4, T. Hickey3, V. Geraghty5

1Stockport Acute Foundation Trust, Gastroenterology, Stockport, UK, 2Macclesfield Hospital, Gastroenterology, Macclesfield, UK, 3Royal Blackburn Hospital, Gastroenterology, Blackburn, UK, 4University Hospital Of South Manchester, Gastroenterology, Manchester, UK, 5University Of South Manchester, Gastroenterology, Manchester, UK

N035: The use of intravenous (IV) ferric carboxymaltose in a paediatric IBD populationECCO '18 Vienna
Year: 2018
Authors:

K. Crook*, T. Tyrrell, W. Hyer

St Mark's Hospital, Paediatric Gastroenterology, Harrow, UK

N036: The advanced nursing care in IBD: Study on biosimilar drugsECCO '18 Vienna
Year: 2018
Authors:

F.M. Onidi*, S. Simbula, V. Vacca, L. Binaghi, M. Pellecchia, F. Cabras, M. Demurtas, G. Mocci

Gastroenterology Unit Brotzu Hospital, Cagliari, Italy

N037: Attitudes of Crohn’s disease patients toward self-monitoring trough an AppECCO '18 Vienna
Year: 2018
Authors:

M.C. Morete Pérez*, V. Ollero, R. Fraga, A. Lopez, A. Echarri

Complejo Hospitalario Universitario de Ferrol, Unidad de EICI, Servicio de Digestivo, Ferrol, Spain

NO001: Cognitive behavioural therapy for the management of inflammatory bowel disease-fatigue: A pilot randomised controlled trial12th N-ECCO Network Meeting
Year: 2018
Authors:

M. Artom*, W. Czuber-Dochan, J. Sturt, H. Proudfoot, C. Norton

King's College London, Florence Nightingale Faculty of Nursing and Midwifery, London, UK

NO002: Increasing research capacity of IBD nurses across Europe—a case study of Inflammatory Bowel Disease Fatigue (IBD-F) scale translation and validation12th N-ECCO Network Meeting
Year: 2018
Authors:

W. Czuber-Dochan1*, M. Artom1, C. Norton1, A. Andonova2, M. Pencova2, V. Cluzeau3, M. Chalabreysee3, R. Barkan4, I. Goren4, L. Shpoker5, S. Radice6, E. Schiavoni7, A. Cocchieri8, D. Napolitano9, L. Turchini9, M. Zega9, L.P. Jelsness-Jørgensen10, A. Giner-Agudo11, R. Barastegui11, C. Fernández-Fernández12, M. Gallego11, F. Murciano13, E. Navarro14, A. Rivera15, A. Vara-Hernández16, S. Jäghult17, K. Pihl Lesnovska17, A. der Heer-Damen18, A. Heil18, L. Moortgat19

1King's College London, Faculty of Life Sciences and Medicine, Department of Nutritional Sciences, London, UK, 2Trakia University, Faculty of Medicine, Stara Zagora, Bulgaria, 3Hôpital Archet2- 4èmeB- CHU de Nice, Pôle digestif- Nutrition Clinique, Nice, France, 4Rabin Medical Center - Beilinson Hospital, Department of Gastroenterology, Petah Tikva, Israel, 5Bnai Zion Medical Center, Gastroenterology Department, Haifa, Israel, 6Instituto Clinico Humanitas, Rozzano, Italy, 7Fondazione Policlinico Universitario Agostino Gemelli, Gastroenterology and Hepatology Group, Roma, Italy, 8Fondazione Policlinico Universitario Agostino Gemelli, Gastroenterology and Hepatology, Rome, Italy, 9Fondazione Policlinico Universitario Agostino Gemelli, Gastroenterology and Hepatology, Roma, Italy, 10Ostfold University College, Halden, Norway, 11Hospital Clinic Barcelona, Gastroenterology, Barcelona, Spain, 12Hospital Ramón y Cajal, Gastroenterology, Madrid, Spain, 13Hospital del Mar, IBD and Digestology Department, Barcelona, Spain, 14Vall Hebron Universitary Hospita, IBD Unit Gastroenterology Department, Barcelona, Spain, 15Hospital San Juan de Dios del Aljarafe, Internal Medicine, Seville, Spain, 16Hospital Clínic de Barcelona, IBD Unit Gastroenterology Department, Barcelona, Spain, 17Stockholm Gastro Center, Stockholm, Sweden, 18Elisabeth-TweeSteden Ziekenhuis, Gastroenterology and Hepatology, Tilburg, The Netherlands, 19Az Delta Hospital, Roeselare, Belgium

NO003: The quality of care questionnaire—development of a valid measure for persons with inflammatory bowel disease12th N-ECCO Network Meeting
Year: 2018
Authors:

K. Pihl Lesnovska1*, S. Börjeson2, G. Hollman Frisman3, H. Hjortswang4, M. Wenemark5

1University hospital of Linköping, Gastroenterology and hepatology, Linköping, Sweden, 2Faculty of Medicine, Linköping University, Department of Medical and Health Sciences, Linköping, Sweden, 3Department of Medical and Health Sciences, Linköping University, Department of Anaesthesiology and Intensive Care, Linköping, Sweden, 4Clinical and Experimental Medicine, Linköping University, Department of Gastroenterology and Department, Linköping, Sweden, 5Department of Medical and Health Sciences, Linköping University, Centre for Organisational support and Development, Linköping, Sweden

OP001: Gut barrier dysfunction: a primary defect in twins with Crohn’s disease predominantly caused by genetic predispositionECCO '18 Vienna
Year: 2018
Authors:

Å.V. Keita1, C.M. Lindqvist2, Å. Öst3, C.D.L. Magana1, I. Schoultz2, J. Halfvarson4*

1Linköping University, Department of Clinical and Experimental Medicine, Linköping, Sweden, 2Örebro University, Department of Medical Sciences, Örebro, Sweden, 3Aleris Medilab, Department of Pathology and Cytology, Täby, Sweden, 4Örebro University, Department of Gastroenterology, Örebro, Sweden

OP002: Assessment of disease activity patterns during the first 10 years after diagnosis in a population-based Crohn’s disease cohort shows a quiescent disease course for a substantial proportion of the populationECCO '18 Vienna
Year: 2018
Authors:

D. Wintjens1,2*, F. Bergey3, E. Saccenti4, S. Jeuring1,2, M. Romberg-Camps5, L. Oostenbrug5, A. Masclee1,2, D. Jonkers1,2, V. Martins dos Santos3,4, M. Pierik1,2

1Maastricht University Medical Center, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht, The Netherlands, 2Maastricht University Medical Center, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands, 3LifeGlimmer GmbH, Berlin, Germany, 4Wageningen University & Research, Laboratory of Systems and Synthetic Biology, Wageningen, The Netherlands, 5Zuyderland Medical Centre, Department of Gastroenterology and Hepatology, Sittard-Geleen/Heerlen, The Netherlands

OP003: Temporal changes in immune pathways with consecutive biological therapies as measured by serum proteomicsECCO '18 Vienna
Year: 2018
Authors:

M. de Bruyn1,2*, V. Ballet3, S. Verstockt4, B. Verstockt1,3, G. Van Assche1,3, M. Ferrante1,3, K. Machiels1, S. Vermeire1,3

1Translational Research Center for GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism and Ageing (CHROMETA), Leuven, Belgium, 2Rega Institute for Medical Research, Microbiology and Immunology, Leuven, Belgium, 3University Hospitals Leuven, Gastroenterology and Hepatology, Leuven, Belgium, 4Laboratory of Complex Genetics, Human Genetics, Leuven, Belgium